Taking FLIGHT - Summary - MDSpire

Taking FLIGHT

ViaLase announces first commercial FLIGHT procedures in Europe

  • June 18, 2026

  • 2 min

Share

Objective:

To announce the first commercial cases of the FLIGHT procedure, a new non-incisional glaucoma surgery in Europe.

Approach:
    Key Findings:
    • FLIGHT is a minimally invasive, image-guided alternative to traditional glaucoma surgery.
    • The procedure aims to restore aqueous outflow and lower intraocular pressure in patients with open-angle glaucoma.
    • The technology allows for precision treatment without the need to open the eye, addressing an unmet need for incision-free options.
    Interpretation:

    The FLIGHT procedure represents a potential shift in glaucoma intervention, allowing for earlier treatment in the disease continuum.

    Limitations:
    • The FLIGHT procedure is currently only commercialized in Europe and remains investigational in the United States.
    Conclusion:

    The launch of FLIGHT represents an important step for ViaLase in glaucoma care.

    Sources:

Original Source(s)

Taking FLIGHT

  • June 18, 2026

Related Content

New Generic Expands Glaucoma Options

Amneal Pharmaceuticals launches generic bimatoprost 0.01% in US

  • May 11, 2026

  • 2 min
Smoking Doubles Risk of Vision Loss

New research indicates smoking doubles the risk of multiple sight-threatening conditions

  • May 15, 2026

  • 3 min
New UK Framework for Glaucoma Care

Backed by major ophthalmic organizations, new NHS guidance seeks to standardize glaucoma services across England

  • June 4, 2026

  • 2 min